Skip to content

Fortified Skimmed Mother's Milk in the Management of Chylothorax

A Comparison of the Effectiveness of Fortified Skimmed Mother's Milk Versus Specialized Formula in the Management of Chylous Effusion in Infants Following Cardiothoracic Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01673165
Enrollment
17
Registered
2012-08-27
Start date
2012-06-30
Completion date
2015-09-30
Last updated
2015-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chylous Pleural Effusion Following Cardiothoracic Surgery

Brief summary

The purpose of this study is to determine if the use of fortified skimmed mother's milk is a safe alternative to specialized formula in the treatment of chylothorax following cardiothoracic surgery.

Detailed description

A chylothorax is a collection of fluid around the lungs that can occur after cardiac surgery. The fluid contains chyle, a milky fluid consisting of fat droplets. The standard treatment is to feed an infant with a specialized low fat formula for up to 6 weeks until the chest has time to heal. This formula is generally not well tolerated and mother's of our patients have expressed a desire to continue using breast milk. A few case reports have been published, but there have not been any studies to date looking at this. Data will be collected to include information about nutrition, weight gain, teaching needs, surgical, hospital, and discharge information.

Interventions

OTHERSkimmed mother's milk

Fortified skimmed mother's milk will be given to the skimmed mother's milk group. The fortifier is a standard fortifier we use in our population

OTHERSpecialized Formula

Infants will receive our standard of care - specialized formula

Sponsors

The Gerber Foundation
CollaboratorOTHER
Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 12 Months
Healthy volunteers
No

Inclusion criteria

* Infant birth to 12 months of age * Undergo cardiothoracic surgery * Develop a chylous effusion * Be a breastfed or formula fed infant

Exclusion criteria

* Infant over 12 months of age * Infant in state custody (foster care) * Infant with milk protein allergy * Infant born with congenital chylothorax * Infant who develops chylothorax from other surgeries (non-cardiac

Design outcomes

Primary

MeasureTime frameDescription
To evaluate the time to resolution of chylothorax of infants receiving skimmed mother's milk versus specialized formula.up to 2 months from enrollmentFluid around the lungs is assessed by chest radiographs (x-rays) as per our usual standard of care. Cloudy fluid will be sent for analysis (chylomicrons, cell count, lymphocytes, and triglycerides) to confirm the diagnosis. The date of diagnosis, the date of chest tube removal, and the date of resolution of effusion by chest xrays

Secondary

MeasureTime frameDescription
To evaluate the recurrence rate of chylous effusion in infants receiving skimmed mother's milk versus specialized formula.up to 4 months after hospital dischargeAll patients receive a standard chest x-ray prior to discharge from the hospital and again in two weeks at their follow up appointment. If symptoms of respiratory difficulty occur prior to or following this time, additional chest x-rays may be obtained based on exam findings and clinical judgment. The date of recurrence of effusion will be recorded as will the date of chest tube insertion if required.
To evaluate the technique of skimming and fortifying breast milkthe first 30 days after enrollmentThe skimming technique will be taught to participating mothers and nurses caring for their infants. A sample of the skim milk will be analyzed by a creamatocrit for fat and caloric content.
To compare feeding tolerance, growth, and nutrition in infants who receive fortified skimmed mother's milk versus specialized formula2 monthsFeeding symptoms observed by clinical staff and parents will be recorded. Parents will complete a questionnaire and score symptoms based on severity. Infants will be monitored as per our usual standard of care with weights, length measurements, and monitoring intake to ensure adequate growth

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026